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Aspergillus fumigatus is an opportunistic environmental mold that can cause severe
allergic responses in atopic individuals and poses a life-threatening risk for severely
immunocompromised patients. Infection is caused by inhalation of fungal spores (conidia)
into the lungs. The initial point of contact between the fungus and the host is a
monolayer of lung epithelial cells. Understanding how these cells react to fungal contact
is crucial to elucidating the pathobiology of Aspergillus-related disease states. The
experimental systems, both in vitro and in vivo, used to study these interactions,
are described. Distinction is made between bronchial and alveolar epithelial cells. The
experimental findings suggest that lung epithelial cells are more than just “innocent
bystanders” or a purely physical barrier against infection. They can be better described
as an active extension of our innate immune system, operating as a surveillance
mechanism that can specifically identify fungal spores and activate an offensive response
to block infection. This response includes the internalization of adherent conidia and
the release of cytokines, antimicrobial peptides, and reactive oxygen species. In the case
of allergy, lung epithelial cells can dampen an over-reactive immune response by releasing
anti-inflammatory compounds such as kinurenine. This review summarizes our current
knowledge regarding the interaction of A. fumigatus with lung epithelial cells. A better
understanding of the interactions between A. fumigatus and lung epithelial cells has
therapeutic implications, as stimulation or inhibition of the epithelial response may alter
disease outcome.
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Aspergillus fumigatus is a ubiquitous saprophytic mold with
a worldwide distribution (Ben-Ami et al., 2010; McCormick
et al., 2010). Inhalation of A. fumigatus asexual spores (coni-
dia) can cause a spectrum of clinical manifestations depend-
ing on the immunological status of the host (Ben-Ami et al.,
2010; McCormick et al., 2010). In the hypersensitive host, coni-
dia inhaled primarily into the bronchial tree can initiate an
allergic response culminating in Allergic Bronchopulmonary
Aspergillosis (ABPA) (Knutsen and Slavin, 2011). In the
immunocompromised host, conidia inhaled mainly into the
lung alveoli can cause a life-threatening fungal infection termed
Invasive Pulmonary Aspergillosis (IPA) (Hope et al., 2007;
Thompson and Patterson, 2011).
In both cases, the initial point of contact between the fungus
and the host is a monolayer of lung epithelial cells. Elucidating
how these cells react to fungal contact is central to our under-
standing of Aspergillus-associated diseases. However, remarkably,
during the last 20 years, very little research has focused on
understanding the interactions between lung epithelial cells and
A. fumigatus. Less than 40 publications directly dealing with this
topic were found during the preparation of this manuscript, com-
pared to many hundreds of papers describing the interactions of
A. fumigatus with various immune cells.
In contrast, the study of lung epithelial responses to bacterial
and viral pathogens is relatively advanced, suggesting that similar
progress can be expected in the field of fungal interactions (Evans
et al., 2010; Vareille et al., 2011).
In this review, I will outline themain findings to date regarding
lung epithelial cell interactions with A. fumigatus and identify key
areas of research that, in my opinion, need to be further pursued
with vigor.
BRONCHIAL AND ALVEOLAR EPITHELIUM-STRUCTURE
AND FUNCTION
The bronchi (singular bronchus) are tubes that allow passage of
air into the lung alveoli. They further divide into primary bron-
chioles and finally into terminal bronchioles connected directly
to the alveoli. No exchange of gases takes place in the bronchial
structure. A mid-level primary bronchiole is made up of three
layers—an inner layer of epithelial cells, a middle layer of con-
nective tissue, and an elastic outer layer of smooth muscle cells
(Figure 1). The inner layer of epithelial cells is composed mainly
of mucus-secreting goblet cells and ciliated cells that drive the
mucus and adherent debris, out of the lungs. In ABPA, inhaled
conidia initiate an exaggerated Th-2 mediated inflammatory
response. Following activation by T-cell cytokines, epithelial cells
www.frontiersin.org September 2012 | Volume 3 | Article 346 | 1
Osherov Lung epithelium and Aspergillus fumigatus
FIGURE 1 | Structure of the lung airways and the development of ABPA.
The major epithelial cell types in the airways are the ciliated, goblet, and
basal cells. They are attached to connective tissue that is surrounded by a
band of smooth muscle cells. In ABPA, a Th2-mediated response to inhaled
A. fumigatus conidia results in enhanced mucus production and the influx of
eosinophils and neutrophils from the bloodstream into the airway. These cells
inflame and damage the airway, resulting in tissue fibrosis and subsequently
bronchiectasis.
release large quantities of proinflammatory cytokines, growth fac-
tors and chemokines, amplifying the influx of T-cells, eosinophils,
basophils, and other inflammatory cells. This inflammation leads
to the associated pathological features of airway hyperrespon-
siveness, hyperplasia/metaplasia of goblet cells and subepithelial
fibrosis (Kato and Schleimer, 2007; Knutsen and Slavin, 2011).
The alveolar epithelium covers a surface area of approximately
100m2 and contains over 700 million individual alveoli, each
about 200 microns across. The alveolar membrane is made up
of three layers (Herzog et al., 2008) (Figure 2): The inner layer
contains two types of epithelial cells: (1) terminally differentiated
non-dividing type I cells covering >95% of the inner alveolar
surface. These cells are extremely thin (<0.5 microns), enabling
rapid gas exchange (2) type II cells, whose primary roles are
to secrete surfactant proteins and differentiate into type I cells.
Binding of surfactant proteins A and D to A. fumigatus conidia
enhances phagocytosis and killing by neutrophils and alveolar
macrophages (Madan et al., 1997, 2005; Kishor et al., 2002;
Pandit et al., 2012). In addition, type II cells secrete cytokines,
chemokines, and antimicrobial peptides in response to pathogens
(Herzog et al., 2008). The alveolar epithelial cells are attached
to a thin basal membrane layer composed of connective tis-
sue proteins including laminin and fibronectin. Attached to the
undersurface of the basal membrane is a single layer of capillary
endothelial cells, that line the blood vessels coming into contact
with the alveoli. In IPA, inhaled conidia, because of their small
size (2–3microns) enter the alveoli and proceed to germinate. The
entire alveolar tissue is in most places no wider than 1 micron, so
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FIGURE 2 | Structure of the alveolus and the development of IPA. The
major epithelial cell types of the alveolus are the type I and type II
pneumocytes. They are attached to a thin basal membrane composed of
laminin, collagen, and fibronectin. A single layer of capillary endothelial
cells is attached to the lower side of the basal membrane, lining the
blood vessel. In IPA, inhaled conidia germinate on the alveolar surface.
Immunocompromised patients cannot mount an effective Th1/Th17 based
cellular response involving resident alveolar macrophages and infiltrating
neutrophils, resulting in conidial germination and hyphal penetration
through the thin alveolar wall. Subsequently, profuse hyphal growth
blocks the underlying blood vessels, leading to tissue necrosis and ultimately
death.
that a fungal germ-tube measuring only 2–3 microns long can
easily traverse it and enter the bloodstream. In immunocompe-
tent individuals, resident alveolar macrophages normally ingest
and destroy inhaled conidia. If the fungal inoculum is large, they
secrete chemokines to recruit circulating neutrophils that can
destroy both conidia and growing hyphae. In immunodeficient
individuals, these innate immune defenses are lacking or dysfunc-
tional, leading to fungal growth through the alveolar wall into the
surrounding blood vessels, causing circulatory obstruction and
subsequent tissue necrosis.
EXPERIMENTAL SYSTEMS CURRENTLY USED TO
STUDY THE INTERACTION BETWEEN A. fumigatus
AND LUNG EPITHELIAL CELLS
The in vitro experimental systems developed for studying the
interaction between A. fumigatus and lung epithelial cells are,
for the most part, remarkably basic and simple. Dormant
A. fumigatus conidia or culture filtrate (CF) secreted by mature
mycelium are added to epithelial cells in culture. Most models
of bronchial infection use immortalized (i.e., BEAS-2B and
HBE)(Balloy et al., 2008; Alekseeva et al., 2009; Fekkar et al.,
2012) or cancerous (i.e., H292)(Oguma et al., 2011) bronchial
epithelium cell lines. In some cases primary nasal or tracheal
cells, usually taken from a biopsy (Amitani et al., 1995; Paris
et al., 1997; Botterel et al., 2008) or even whole excised tissue
blocks (Amitani and Kawanami, 2009) have been used. Models of
alveolar infection have been more limited because of the difficulty
in growing primary type I or type II cells in culture. Only very
recently has a stable transformed type I cell line been generated
but has not yet entered experimental use (Thorley et al., 2011).
Due to a lack of a better system, almost all studies of alveolar
epithelial infection use the type II-like A549 cell line derived
from a lung carcinoma (Lieber et al., 1976), despite the fact that
these cells cover less than 5% of the alveolar surface. In addition,
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A549 cells are hypotriploid and genetically unstable, and when
cultured as monolayers, they do not retain the structural or
functional characteristic of the original tissue from which they
were derived (Carterson et al., 2005).
The majority of studies have focused primarily on the micro-
scopic analysis of conidial internalization and cell penetration of
infected cells (DeHart et al., 1997; Paris et al., 1997; Wasylnka
and Moore, 2002, 2003; Botterel et al., 2008; Han et al., 2011),
the subsequent release of cytokines (Tomee et al., 1997; Borger
et al., 1999; Kauffman et al., 2000; Zhang et al., 2005; Bellanger
et al., 2009; Sun et al., 2012) and the activation of signaling pro-
teins and pathways (Han et al., 2011; Balloy et al., 2008; Sharon
et al., 2011). Transcriptome and proteomic analyses have recently
been used to identify novel responses and pathways activated in
infected cells (Gomez et al., 2010; Oosthuizen et al., 2011; Sharon
et al., 2011; Fekkar et al., 2012). A major advance towards a
more credible in vitro model has been the development of a cel-
lular bilayer system constructed with human alveolar epithelial
cells and human pulmonary artery endothelial cells grown on
either side of a semipermeable polyester membrane (Hope et al.,
2007; Gregson et al., 2012). There have been relatively few in-vivo
studies analyzing the interaction between A. fumigatus and lung
epithelial cells possibly because of the complexity of the immune
response and the difficulty in getting reliable readouts from the
epithelial cells alone (Kheradmand et al., 2002; Porter et al., 2009;
Cunha et al., 2010; de Luca et al., 2010).
THE INTERACTION OF A. fumigatus WITH BRONCHIAL
EPITHELIAL AND NASAL EPITHELIAL CELLS
Several groups have undertaken microscopic examinations of
bronchial or nasal epithelial cells in culture, infected with live
A. fumigatus conidia (Amitani et al., 1995; Paris et al., 1997;
Botterel et al., 2008; Amitani and Kawanami, 2009). They demon-
strated that approximately 20–50% of adherent conidia are inter-
nalized into late phagosomes where they remain ungerminated
(Figure 3) (Botterel et al., 2008; Gomez et al., 2010). However, as
most internalized conidia remain viable for up to 20 h, they may
serve as a possible reservoir of infection. Externally adherent coni-
dia proceed to germinate, causing damage to the cells (Figure 3).
When grown on a biopsy of human bronchial tissue, hyphae pen-
etrate through both intercellular and intracellular spaces of the
epithelium, leading to loss of cilia and cell detachment (Amitani
and Kawanami, 2009).
Balloy et al. (2008) examined the signaling pathways activated
in bronchial epithelial (BEAS-2B) cells after conidial infection.
Germinating but not resting conidia of A. fumigatus activated
phosphatidylinositol3-kinase (PI3K), p38 mitogen activated pro-
tein kinase (MAPK), and ERK1/2 leading to interleukin (IL)-8
synthesis (Figure 3). The MyD88 pathway was also activated by
A. fumigatus, leading to NF-κB activation; however, IL-8 produc-
tion was not dependent on the TLR-MyD88 pathway. Therefore,
two independent signaling pathways are activated in BEAS-2B
cells by A. fumigatus, one that is MyD88/NF-κB-dependent and
another that is PI3K/p38/ERK1/2-dependent and involved in IL-8
synthesis.
Human bronchial epithelial cells apparently recognize and
respond to A. fumigatus through dectin-1 receptors that bind
FIGURE 3 | Interaction of A. fumigatus with a bronchial epithelial cell.
Approximately 30% of adherent A. fumigatus conidia undergo
internalization into endosomes which subsequently fuse to form acidic
phagosomes. This process is dependent on the polymerization of actin
around the endosome. Most ingested cells remain alive in the acidic
phagosomes for up to 20h. Approximately 70% of adherent A. fumigatus
conidia germinate externally, activating MyD-dependent NFkB, PI3 kinase,
and MAP kinase signaling, leading to chemokine and cytokine synthesis in
a dectin-1 dependent manner. A. fumigatus infection also stimulates,
through as yet unknown signaling pathways, the production of antimicrobial
defensins and cell degranulation. Proteases secreted by the fungus also
activate the production of cytokines.
glucan exposed on the fungal surface (Cunha et al., 2010; Sun
et al., 2012) by generating reactive oxygen species, antimicrobial
peptides and cytokines (Figure 3). Inhibition of dectin-1 expres-
sion by RNAi blocked these responses. Interestingly, dectin-1 is
present at low levels on the surface of these cells under nor-
mal conditions and is strongly upregulated in a TLR2-dependent
manner in response to germinating conidia (Sun et al., 2012).
This suggests that HBE cells have the ability to distinguish
between dormant and germinating conidia and can increase the
sensitivity and strength of their response over time.
The transcriptional response of bronchial epithelial cells in
culture to infection by A. fumigatus conidia has been recently
analyzed (Gomez et al., 2010; Oosthuizen et al., 2011). Gomez
et al. (2010) analyzed the response of the specific subset of
HBE cells that had internalized conidia following 6 h of infec-
tion. These cells had increased levels of transcripts from genes
associated with repair and inflammatory processes (e.g., matrix
metalloproteinases, chemokines, and glutathione S-transferase).
Also enriched and upregulated were genes involved in chromatin
assembly, G-protein-coupled receptor binding, chemokine activ-
ity, and glutathione metabolic processes, consistent with their
established role in responding to fungal invasion in myeloid cells
(Cortez et al., 2006). Genes involved in cell cycle phase, mitosis,
and intracellular organelles were downregulated, suggesting that
the infected cells reduced their rate of proliferation in response
to direct interaction with conidia. Oosthuizen et al. (2011) ana-
lyzed the transcriptional response of both HBEs and A. fumigatus
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during infection. The response of the infected HBE cells was weak
and did not overlap well with the results reported by Gomez et al.
(2010). However, in both studies the innate immune response and
the production of chemokines were increased.
Only a single publication has analyzed the proteomic response
of A. fumigatus-infected bronchial (BEAS-2B) cells, limited to
identifying the secreted proteins (Fekkar et al., 2012). Seven
secreted proteins of human origin were significantly increased
following infection, including three of lysosomal origin and four
participating in the thioredoxin system. The release of lysosomal
enzymes was dose-dependent and activated only by live conidia.
It was partly dependent on the PI3K and p38-MAPK pathways.
This result suggests that bronchial cells react to fungal infection
by lysosomal degranulation and the release of proteins belonging
to the redox detoxification system that may protect them from
damage caused either by infection or by the host inflammatory
response. However, at least in this cell-culture-based study, the
fungus completely overwhelmed the cells and their degranulation
did not seem to cause damage to the fungus.
Beta-defensins (hBDs) are antimicrobial peptides secreted by
the lung epithelium in response to pathogens (Tecle et al., 2010).
When bronchial or alveolar (A549) cells were infected with live
swollen conidia they responded by secreting the defensins hBD2
and hBD9. However, the concentration of secreted defensins was
too low to affect fungal growth in this model system.
In summary, the studies described here confirm that infected
airway epithelial cells are not passive; they respond offensively
by secreting lysosomal enzymes, antimicrobial peptides, and
cytokines that alert and activate the immune system.
A methodological limitation of these experiments is that it is
not possible to follow A. fumigatus cell infection for longer than
∼24 h. After that period, profuse hyphal growth causes the cells
to detach and die. Therefore, CF derived from mature mycelial
culture has been used as an imperfect substitute to simulate some
aspects of late infection. CF is prepared from A. fumigatus grown
in cell culture medium for 2 days to a week. The mycelium is
then removed, the medium is filtered to remove microorganisms
and added to the epithelial cells in culture (Amitani et al., 1995;
Tomee et al., 1997; Zhang et al., 2005; Sharon et al., 2011). When
CF was added to primary ciliated nasal cells, it slowed ciliary
beat frequency and caused epithelial disruption. Fractionation of
the CF showed that the active fraction consisted of gliotoxin and
other uncharacterized high-molecular-weight factors secreted by
the fungus (Amitani et al., 1995). If these factors are produced
in sufficient quantity in vivo, they could be important in the
pathogenesis of A. fumigatus airway infections.
CF also induces the release of pro-inflammatory cytokines
(IL-6, IL-8, and MCP-1) and mucin in treated H292 bronchial
and primary nasal epithelial cells (Tomee et al., 1997; Kauffman
et al., 2000; Oguma et al., 2011). Cytokine release, mucin secre-
tion and cell peeling were blocked by addition of serine protease
inhibitors, suggesting that secreted fungal proteases were respon-
sible for these effects. By causing cell detachment, fungal proteases
may decrease the ability of the epithelium to function as a physical
barrier. In response, the epithelium may initiate an inflammatory
mucosal response against A. fumigatus by releasing cytokines and
secreting mucin.
The role of secreted fungal proteases in the development of
asthma was also demonstrated in a mouse model (Kheradmand
et al., 2002; Porter et al., 2009). A complete asthma phenotype,
characterized by airway hyperresponsiveness, airway eosinophilia
and recruitment of IL-4- and IFN- γ-secreting cells did not fully
develop when mice were challenged intranasally with a protease-
deficient strain of Aspergillus niger or allergen pretreated with
protease inhibitors. These results suggest that as in cell cul-
ture, infected lung epithelial cells respond primarily to proteases
secreted by the fungus, triggering an allergic response.
An important aspect of the lung response to pathogens, espe-
cially in allergy, is that the initial inflammatory response must be
dampened, to enter a state of immunological tolerance. de Luca
et al. (2010), recently demonstrated that addition of A. fumiga-
tus conidia to primary bronchial cells activated the secretion of
kinurenine, an anti-inflammatory molecule. Kinurenine is syn-
thesized from tryptophan by the enzyme indoleamine 2,3 dioxy-
genase (IDO). IDO was shown to be activated in these cells by
the TLR3-TRIF- NF-κB pathway, as bronchial cells from knock-
out mice in these genes, did not release kinurenine in response
to A. fumigatus conidia. Alveolar inflammation and neutrophil
influx in the Trif−/− mice was strongly increased as compared to
normal mice.
THE INTERACTION OF A. fumigatus WITH THE
ALVEOLAR EPITHELIUM
As described above, almost all studies analyzing the interaction of
A. fumigatus with alveolar epithelial cells have been undertaken in
cell culture using A549 cells, a cancer-derived (adenocarcinoma)
cell line originating from type II cells (Bromley and Donaldson,
1996; DeHart et al., 1997; Paris et al., 1997; Tomee et al., 1997;
Borger et al., 1999; Daly et al., 1999; Kauffman et al., 2000; Daly
and Kavanagh, 2002; Wasylnka and Moore, 2002, 2003; Kogan
et al., 2004; Zhang et al., 2005; Alekseeva et al., 2009; Bellanger
et al., 2009; Han et al., 2011; Sharon et al., 2011). Early stud-
ies established that A. fumigatus conidia preferentially adhere to
A549 monolayers and to the extracellular matrix they secrete
(Bromley and Donaldson, 1996; DeHart et al., 1997). Infected
cells form pseudopods surrounding some of the bound conidia
followed by invagination and endocytosis (Paris et al., 1997). As
in the bronchial airway epithelium, about 1/3 of adherent conidia
are endocytosed, whereas the rest germinate externally, penetrat-
ing and damaging the cells (Wasylnka and Moore, 2002, 2003;
Bellanger et al., 2009). During endocytosis, an actin ring encircles
the endosome containing the conidium. Internalization is actin-
dependent as it is blocked by depolymerization with cytocha-
lasin D (Wasylnka and Moore, 2002). Conidia are trafficked into
acidic phagosomes where only 3% survive after 24 h (Figure 4)
(Wasylnka and Moore, 2003). Surprisingly, one third of these
surviving conidia germinate and escape the phagosome, forming
extracellular hyphae without lysing the host cell. Internalization
seems to involve conidial binding to cell-surface dectin 1 recep-
tors and activation of phospholipase D (PL-D) activity, which
is inhibited by dectin-blocking antibodies or PL-D inhibitors
(Figure 4) (Han et al., 2011). Taken together, these results sug-
gest that A549 cells behave as non-professional phagocytes. They
differ from macrophages and other professional phagocytic cells
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FIGURE 4 | Interaction of A. fumigatus with an A549 type II alveolar
epithelial cell. Approximately 30% of adherent A. fumigatus conidia are
internalized into endosomes which subsequently fuse to form acidic
phagosomes. This process is dependent on dectin 1 receptors on the cell
surface, and the phospholipase-D dependent polymerization of actin around
the endosome. Most (97%) ingested conidia are killed in the acidic
phagosomes after 24h. Approximately 70% of adherent A. fumigatus
conidia germinate externally, causing actin cytoskeleton depolymerization
and cell retraction. Proteases secreted by the fungus activate MAP-kinase
signaling, leading to the production of cytokines and subsequently cell
death by necrosis.
in being unable to efficiently process and destroy all ingested
conidia.
The changes induced by conidial infection of A549 cells are
not limited to the point of physical contact with the fungus. Live
adherent conidia initiate rapid (<2 h) A549 cell retraction, loss
of focal adhesions and the depolymerization of the entire F-actin
cytoskeleton. This may enable the fungus to penetrate the thin
underlying basal membrane layer more rapidly and enter the
bloodstream (Kogan et al., 2004; Sharon et al., 2011).
Cytokine (IL-6, IL-8, TNF-α, GM-CSF, and MCP1) produc-
tion is also stimulated in A549 cells in response to live conidia
or mycelial fragments (Zhang et al., 2005; Bellanger et al., 2009;
Sharon et al., 2011). However, unlike in bronchial cells, no studies
have identified the signaling pathways involved. The central sig-
naling kinases JNK and p38 are not phosphorylated in response
to A549 cell conidial infection, whereas ERK1/2 phosphoryla-
tion is only weakly activated, suggesting that these kinases are
not involved in responding to infection (Sharon et al., 2011). The
whole-genome transcriptional response of infected cells indicates
a general protective response, characterized by the activation of
genes participating in intracellular signaling pathways and the
secretion of inflammatory cytokines (Sharon et al., 2011).
The responses induced byA. fumigatusCF in treated A549 cells
are very similar to those described for bronchial epithelial cells.
The cells undergo a rapid loss of actin fibers and focal adhesions,
followed by peeling and necrosis (Kogan et al., 2004; Sharon et al.,
2011). Interestingly, these processes are blocked by addition of
serine protease inhibitors or CF derived from protease-deficient
A. fumigatus mutant strains (Figure 4). CF also induces the rapid
phosphorylation and activation of the MAPKs ERK1/2, JNK, and
p38. Activation depends on the protease activity of the CF, and
does not occur in the presence of CF from a protease deficient
strain of A. fumigatus. Strikingly, specific inhibition of ERK or
JNK kinase activity strongly delays actin depolymerization, cell
peeling and necrosis (Sharon et al., 2011). Together, these results
imply that secreted fungal proteases, through an unknown mech-
anism, activate MAPK signaling in CF-treated A549 cells, leading
to actin depolymerization, cell peeling, and necrosis. In addition,
these findings suggest that inhibition of secreted fungal proteases
or of the MAPK-mediated host response can decrease cellular
damage, a finding with possible clinical implications.
Researchers have recently developed a bilayer model of the
human alveolus that provides novel insights into A. fumiga-
tus infection and treatment (Hope et al., 2007; Gregson et al.,
2012). A549 alveolar cells and primary heart endothelial cells
are grown on the upper and lower surface of a porous mem-
brane, respectively, thereby mimicking the alveolar layers. GFP-
fluorescent A. fumigatus conidia are seeded on the alveolar (A549
cell) side and their growth monitored. After about 15 h, some of
the conidia are endocytosed but most germinate on the alveo-
lar surface traversing both cell layers and the porous membrane
between them. As the fungal hyphae pierce the lower endothelial
layer, they secrete galactomannan into the endothelial compart-
ment that can be quantified as a proxy for fungal invasion.
Addition of macrophages to the top (A549 cell) compartment or
Amphotericin B to the lower (endothelial) compartment partially
delayed fungal invasion, whereas co-administration resulted in
complete suppression of fungal growth (Hope et al., 2007). The
alveolar bilayer model has also recently demonstrated its useful-
ness in addressing questions regarding the pharmacokinetics and
pharmacodynamics of Amphotericin B formulations, itracona-
zole, and voriconazole (Lestner et al., 2010; Al-Nakeeb et al., 2012;
Jeans et al., 2012). With further refinements, such as addition
of type I epithelial cells, basal membrane proteins and various
immune cells, this model can be used to simulate and parse
the molecular signaling events occuring between the various cell
types that make up a functional alveolus.
LUNG EPITHELIAL STIMULATION CONFERS
PROTECTION AGAINST A. fumigatus INFECTION
In an exciting demonstration of the untapped therapeutic
potential of lung epithelial cells, Evans et al. (2008) showed that
mice pretreated with aerosolized bacterial lysates were highly pro-
tected against a broad array of bacterial pathogens, and also, sur-
prisingly, against A. fumigatus. Protection against inhaled conidia
occurred in immunocompromised neutropenic mice through the
activation of multiple host defense signaling pathways in lung
epithelial cells (Evans et al., 2008). These results suggest that
immunodeficient patients at high risk to develop IPA, might ben-
efit from stimulation of lung epithelial cell innate immunity.
Additional approaches based on lung epithelial stimulation that
have demonstrated promise in protection against bacterial infec-
tion include the overexpression of defensins (Shu et al., 2006),
upregulation of NF-κB signaling pathways (Sadikot et al., 2006)
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or the administration of cytokines such as IL-22 and IL-17
that activate lung epithelial cell defenses (Aujla et al., 2008).
These approaches may also provide protection against fungal lung
infections.
SUMMARY AND COMPARISON
In summary, both bronchial and alveolar epithelial cells respond
to A. fumigatus infection not as a simple physical barrier but
as an extension of the innate immune system. They actively
phagocytose a proportion of adherent conidia, and inhibit their
growth. They produce cytokines and chemokines that activate
both innate and acquired immunity and secrete antimicrobial
peptides and lysosomal enzymes that may inhibit fungal growth.
The signaling pathways involved in these processes have begun
to be clarified. However, considerable gaps in our knowledge
remain. Surprisingly, even less is known regarding the interac-
tion of lung epithelial cells and other inhaled fungal pathogens
such as Cryptococcus neoformans, Paracoccidioides brasiliensis, and
Histoplasma capsulatum. C. neoformans apparently uses the cap-
sular polysachharide GXM and secreted phospholipase B to bind
to A549 cells via the CD14 receptor, leading to rapid internaliza-
tion (45% after 1 h), cytokine and chemokine production and
overwhelming cell lysis after 18 h (Barbosa et al., 2006, 2007;
Ganendren et al., 2006; Guillot et al., 2008). P. brasiliensis binding
to A549 cells is mediated by at least two laminin binding receptors
and involves major cytoskeletal rearrangements in both the yeast
and host cell. Internalization leads to A549 cell death by apop-
tosis after 24–48 h of infection (Mendes-Giannini et al., 2008).
H. capsulatum is endocytosed by tracheal epithelial cells but the
mechanism of recognition and cellular response remain unknown
(Eissenberg et al., 1997).
Perhaps more insight can be gained by comparing the findings
described in this review to the “state of the art” in the study of the
interaction of the specialized bacterial pathogen Mycobacterium
tuberculosis and lung epithelial cells (Krishnan et al., 2010).
M. tuberculosis invades lung epithelial cells prior to dissemina-
tion. Heparin binding haemagglutinin adhesin (HBHA) enables
M. tuberculosis to bind to sulphated glycoconjugates on epithe-
lial cells. The bacteria undergo endocytosis into endosomes but
escape killing by inducing phagosomal maturation arrest (PMA).
Following intracellular replication, M. tuberculosis secretes lytic
proteins (ESAT-6 and CFP-10) that lyse the infected cells enabling
rapid bacterial spreading to the underlying endothelium and to
adjacent epithelial cells.
It is doubtful however, that A. fumigatus, a non-specialized
saprophyte, has evolved similar highly specialized mycobacterial-
like adhesins and lytic proteins.
OPEN QUESTIONS
The field of lung epithelial cell research andA. fumigatus infection
is likely to be advanced significantly by addressing the following
unresolved issues: (1) at the systems level, who is the primary
initiator of the lung inflammatory response to A. fumigatus infec-
tion? Is it the epithelial cells or the immune cells? What is the rela-
tive contribution of each? What are the main differences between
the responses of bronchial and alveolar epithelial cells? How do
they drive either an allergic Th2 response in ABPA or a Th1 cell
mediated response in IPA? How do they interact and communi-
cate bidirectionally with the different lineages of innate and adap-
tive immune cells to drive either one of these responses? (2) At the
cellular level, do lung epithelial cells respond in a graded fashion
to different morphotypes of the fungus or to increasing inocu-
lum? How is the response downregulated? Is the apical response
of lung epithelial cells different from the basolateral response?
For example do they secrete antimicrobial peptides apically,
toward the pathogen, and chemotactic mediators basolaterally,
towards the blood vessels? How are gap junctions involved in host
defense and cell–cell communication along the epithelial surface?
(Thompson and Patterson, 2011) At the subcellular level-are Toll-
like receptors involved in the lung epithelial response to A. fumi-
gatus infection? How do secreted fungal proteases induce lung
epithelial responses? Do they function by cleaving PAR-2 pro-
tease activated receptors? Do lung epithelial cells use additional
mechanisms to disrupt fungal growth (i.e., synthesis of lysosyme,
lactoferrin, calprotectin, SLPI protease inhibitors, etc.), and to
initiate an inflammatory response (i.e., synthesis of leukotrienes
and calprotectin). By what receptors and signaling pathways are
they activated? Do these molecules also serve as ligands that bind
to and activate/inactivate epithelial and immune cells?
I believe that by addressing these important questions, one can
be optimistic for the development of novel intervention strate-
gies aimed at specifically modulating the response of the lung
epithelium to enable us to harness its defensive and offensive
capabilities.
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